HIV/AIDS

More than 33 million people around the world are currently living with human immunodeficiency virus (HIV). While huge progress has been made in increasing access to HIV treatment in the past decade and new HIV infections have substantially declined in some regions, the pandemic continues to outpace efforts to control it. The number of newly infected people each year outnumbers those who gain access to treatment by two to one.

Defeating HIV will require a comprehensive response, and effective programs must be scaled up to treat people already infected and prevent new infections. New tools are also needed to defeat the pandemic, and investment in research and development for new products remains essential. UCSF researchers address issues across the range of HIV/AIDS studies.

Explore Related Topics

Active Projects: 210

Project Investigator
All Topics Start date End date
Relationship Factors and Engagement in HIV Care in Malawi: A Dyadic Investigation HIV/AIDS, Engagement in Care
ACTG: AIDS Clinical Trials Group Francesca T. Aweeka, PharmD HIV/AIDS, Opportunistic Infection
Optimizing ACT use for African children in the setting of HIV and malnutrition Francesca T. Aweeka, PharmD HIV/AIDS, Malaria, Malnutrition, Micronutrients, Food Insecurity
Understanding mobility and sexual mixing in SEARCH communities Carol S. Camlin, PhD HIV/AIDS, Epidemiology and Surveillance, Risk Reduction and Prevention, Patient and Peer Education
Innovative incentive strategies for sustainable HIV testing and linkage to care Gabriel Chamie, MD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Getting to Zero: Advancing Retention and Re-Engagement in HIV Care Demonstration Project Edwin D. Charlebois, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
HVTN 703/HPTN 081 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health
HPTN 082 - Protocol Implementation Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
HPTN 081 Protocol Funding - Development Costs Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Risk Reduction and Prevention
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan C. Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
East Africa IEDEA Regional Consortium Craig Cohen, MD, MPH HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance
Agricultural intervention for food security and HIV health outcomes in Kenya Craig Cohen, MD, MPH HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Health Economics and Policy
Implementation and expansion of high quality, sustainable and comprehensive HIV prevention, care, and treatment to achieve 90-90-90 goals in Western Kenya Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Health Systems Strengthening, Training International Scholars and Clinicians
Implementing Partner: Understanding the HIV prevention needs of men who have sex with men (MSM) and their partners in Southern Africa: KwaZulu-Natal, South Africa and Namibia Lynae Darbes, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Patient and Peer Education
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Steven G. Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven G. Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Programming Long Term Durable HIV-1 Specific T cell Responses Steven G. Deeks, MD HIV/AIDS, Immunology
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven G. Deeks, MD HIV/AIDS, Immunology
Enhancing Control of HIV by Inhibiting TRAIL Steven G. Deeks, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven G. Deeks, MD HIV/AIDS
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph L. Derisi, PhD Infectious Disease, Opportunistic Infection
Improving Mental Health through Integration with Primary Care in Rural Karnataka Maria L. Ekstrand, PhD HIV/AIDS, Neurology and Mental Health, Stigma and Discrimination
Reducing AIDS stigma among health professionals in South India Maria L. Ekstrand, PhD HIV/AIDS
Reducing AIDS stigma among health professionals in South India Maria L. Ekstrand, PhD HIV/AIDS, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Treatment Adherence
AshaCare and Nutrition Program for Rural Indian Women Living with AIDS and Children Maria L. Ekstrand, PhD HIV/AIDS, Women's Health
AshaCare & Nutrition Program for Rural Indian Women Living with AIDS and Children Maria L. Ekstrand, PhD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Women's Health, Pediatrics
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients Maria L. Ekstrand, PhD HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence
International Medical Program for AIDS Clinical Training Mitchell D. Feldman, MD HIV/AIDS, Training International Scholars and Clinicians
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH HIV/AIDS, Women's Health, Newborn and Infant Health, Treatment Adherence
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH HIV/AIDS, Patient and Peer Education
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039) Elvin H. Geng, MD, MPH HIV/AIDS, Epidemiology and Surveillance
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS Elvin H. Geng, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R) Elvin H. Geng, MD, MPH HIV/AIDS, Engagement in Care, Treatment Adherence, Health Systems Strengthening
IeDEA Consortium East Africa data center Elvin H. Geng, MD, MPH HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
AIDS Education and Training Center, National Clinician Consultation Center Ronald H. Goldschmidt, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV, Hahn K24 Judith A. Hahn, PhD, MD HIV/AIDS, Substance Abuse
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith A. Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse
Training in Research Program on Alcohol Use by Persons-with-or-at-Risk for HIV Judith A. Hahn, PhD, MD HIV/AIDS, Substance Abuse
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients Hiroyu Hatano, MD, MHS HIV/AIDS, Noncommunicable and/or Chronic Disease
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa Diane V. Havlir, MD HIV/AIDS, Malaria, Women's Health, Pediatrics
Sustainable East Africa Research in Community Health Diane V. Havlir, MD HIV/AIDS, Epidemiology and Surveillance, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane V. Havlir, MD HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane V. Havlir, MD HIV/AIDS, Tuberculosis
ACTG, AIDS Clinical Trial Research Group Diane V. Havlir, MD HIV/AIDS, Opportunistic Infection
Training in HIV Translational Research Diane V. Havlir, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
SFBay CTU Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV epidemiology and public health Norman Hearst, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Achieving durable retention in care for PMTCT Option B+: An intervention research Jaco Homsy, MD, MPH HIV/AIDS, Women's Health, Pediatrics, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Priscilla Y. Hsue, MD HIV/AIDS
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
Evaluating a community-driven cervical cancer prevention model in western Kenya Megan J. Huchko, MD HIV/AIDS, Cancer/Oncology, Women's Health
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter W. Hunt, MD Infectious Disease, HIV/AIDS, Tuberculosis
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV Peter W. Hunt, MD HIV/AIDS, Immunology
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter W. Hunt, MD HIV/AIDS, Aging
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter W. Hunt, MD HIV/AIDS, Cardiovascular Disease, Chronic Respiratory Disease, Aging
Molecular Biophysics Training Grant (T32 GM008284) Matthew Jacobson, PhD HIV/AIDS, UCSF Professional Education
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations Vivek Jain, MD HIV/AIDS, Drug and Diagnostics Development
AIDS Malignancy Consortium (AMC) Lawrence D. Kaplan, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
HIV Prevention and Care for Peruvian MSM and Transgender Women Susan M. Kegeles, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Community Mobilization to Improve the HIV/AIDS Continuum of Care among Black Men Susan M. Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
Pilot of Culturally Tailored Mpowerment for HIV Prevention Among YMSM in Beirut Susan M. Kegeles, PhD HIV/AIDS, Adolescent Health, Access or Barriers to Care, Risk Reduction and Prevention, Patient and Peer Education
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Sexually Transmitted Infections (STIs), HIV/AIDS
HIV Evaluation Activities with High Risk Underserved Populations in South Africa under PEPFAR Timothy E. Lane, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Peer Navigation to Improve Engagement in Care for HIV-Positive MSM in South Africa Timothy E. Lane, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care, Patient and Peer Education
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan Timothy E. Lane, PhD, MPH HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination
Activating Treatment as Prevention through Community Mobilization in South Africa Sheri A. Lippman, PhD, MPH HIV/AIDS, Engagement in Care, Risk Reduction and Prevention
Multilevel mechanisms of HIV acquisition in young South African women Sheri A. Lippman, PhD, MPH HIV/AIDS, Women's Health, Access or Barriers to Care, Implementation and Behavioral Science
Copy of Innovations in HIV testing to enhance care for young women and their partners Sheri A. Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care
Improving Health Outcomes for Women Living with HIV Sheri A. Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
Epidemiological studies among drug users in Iran Mohsen Malekinejad, MD, DrPH HIV/AIDS, Epidemiology and Surveillance, Substance Abuse
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer Jeffrey N. Martin, MD, MPH HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development
East Africa IEDEA Regional Consortium Jeffrey N. Martin, MD, MPH HIV/AIDS
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology
Timing of ART and homeostasis of the persistent HIV reservoir in the adult J. Michael McCune, MD, PhD HIV/AIDS, Immunology
Early Antiretroviral Therapy and HIV Remission in Perinatal Infection J. Michael McCune, MD, PhD HIV/AIDS
The impact of TB co-infection on the reservoir of persistent HIV in vivo J. Michael McCune, MD, PhD HIV/AIDS, Tuberculosis, Immunology
HIV Implementation Science Research Training Program John J. Metcalfe, MD HIV/AIDS, Training International Scholars and Clinicians
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward L. Murphy, MD, MPH HIV/AIDS, Epidemiology and Surveillance, Training and Capacity Building
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites Edward L. Murphy, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Minority Populations Prevention Researcher Training Torsten B. Neilands, PhD HIV/AIDS, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
The Training Program for Scientists Conducting Research to Reduce HIV/AIDS Health Disparities Torsten B. Neilands, PhD HIV/AIDS, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion G. Peters, MD Infectious Disease, HIV/AIDS
HIV/AIDS Primary Care Capacity in Nursing (PCC) Carmen J. Portillo, RN, PhD, FAAN HIV/AIDS, Training and Capacity Building
HIV/AIDS Primary Care Capacity in Nursing (PCC) Carmen J. Portillo, RN, PhD, FAAN HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Richard W. Price, MD HIV/AIDS
Evolution and Inhibition of Serine Beta-Lactamase Activity Adam R. Renslo, PhD Opportunistic Infection, Drug and Diagnostics Development
Training and Technical Assistance at PAETC- HIV Testing & PrEP E. Michael Reyes, MD, MPH HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Democracy Council Technical Assistance program E. Michael Reyes, MD, MPH HIV/AIDS, International Health Policy
A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination with Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus Philip Rosenthal, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics
NICHD International & Domestic Pediatric & Maternal HIV Studies Coordinating Center Theodore D. Ruel, MD HIV/AIDS, Women's Health, Pediatrics
LOC-IMPAACT Leadership Group Theodore D. Ruel, MD HIV/AIDS, Pediatrics, Newborn and Infant Health, Adolescent Health
Uganda METS M&E (Activity A) George W. Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
Uganda METS CBS (Activity C) George W. Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
UCSF-GSI Technical Assistance in Strategic Information and Health Systems Strengthening under NAM-PHACTS (Program Area C: Strategic Information Activities) George W. Rutherford, MD HIV/AIDS, International Health Policy, Epidemiology and Surveillance, Health Systems Strengthening
Enhancing Strategic Information Capacity for HIV/AIDS Programs in Kenya through Surveillance and Epidemiology and Monitoring and Evaluation under the U.S. PEPFAR (Program Areas A & B) George W. Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Training and Capacity Building, Training International Scholars and Clinicians
Uganda METS HMIS (Activity D) George W. Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Training and Capacity Building
International Traineeships in AIDS Prevention Studies (ITAPS) George W. Rutherford, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Ann V. Schwartz, PhD, MPH HIV/AIDS, Neurology and Mental Health
Culturally relevant PrEP demonstration for trans communities Jeanne M. Sevelius, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Strengthening Mozambican Capacity in Strategic Information Systems under the President's Emergency Plan for AIDS Relief Starley B. Shade, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Global Strategic Information, Training and Capacity Building, Training International Scholars and Clinicians
International Maternal Pediatric Adolescent AIDS Clinical Trial Group Master Member Agreement John A. Shepherd, PhD HIV/AIDS, Women's Health, Newborn and Infant Health, Adolescent Health
Pediatric HIV/AIDS Cohort Study (PHACS) Caroline Shiboski, DDS, MPH, PhD HIV/AIDS, Pediatrics
Reproductive Tract Effects of the Intrauterine Device: Implications for HIV Risk Karen S. Smith-McCune, MD, PhD HIV/AIDS, Family Planning
International Clinical Research Fellowship Christopher C. Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Humanized Mouse Models for HIV Therapeutics Development Cheryl A. Stoddart, PhD HIV/AIDS
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis C. Tien, MD Infectious Disease, HIV/AIDS
Molecular Mechanisms of Oral HIV Transmission Modeling MTCT Sharof Tugizov, PhD HIV/AIDS
Therapeutic Interventions during Acute Infection to Address the CNS Reservoir for HIV Victor G. Valcour, MD, PhD HIV/AIDS
Interventions for Symptom Management in Older Patients with HAND Victor G. Valcour, MD, PhD HIV/AIDS, Dementia and Cognitive Impairment
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition Victor G. Valcour, MD, PhD HIV/AIDS, Aging
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition Victor G. Valcour, MD, PhD HIV/AIDS, Dementia and Cognitive Impairment, Residencies, Fellowships, and Postdoctoral Training
Recent Advances in AIDS and HIV Research Paul A. Volberding, MD HIV/AIDS
amfAR Institute for HIV Cure Research Paul A. Volberding, MD HIV/AIDS, Drug and Diagnostics Development
UCSF-GIVI Center for AIDS Research (CFAR) Paul A. Volberding, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians
Recent Advances in AIDS and HIV Research Paul A. Volberding, MD HIV/AIDS
Development of a UCSF-Gladstone CFAR Health Disparities Core Paul A. Volberding, MD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Changing Health through Food Support (CHeFS) Program- Expanded Program Sheri D. Weiser, MD HIV/AIDS, Diabetes, Malnutrition, Micronutrients, Food Insecurity
Mechanisms and longitudinal effects of HIV-related stigma on women's adherence and outcomes Sheri D. Weiser, MD HIV/AIDS, Women's Health, Implementation and Behavioral Science, Treatment Adherence
Pathways contributing to racial disparities among HIV clinic cohort patients Sheri D. Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Epidemiology and Surveillance
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV, WEISER CONTINUTATION Sheri D. Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity
Impact and Cost-effectiveness of Safer Conception Strategies for HIV Prevention Joelle M. Brown, PhD HIV/AIDS, Women's Health, Family Planning, Health Economics and Policy, Implementation and Behavioral Science, Risk Reduction and Prevention
Impact and Cost-effectiveness of Safer Conception Strategies for HIV Prevention Joelle M. Brown, PhD HIV/AIDS, Family Planning
Optimizing HIV counseling testing and referral through an adaptive drug use intervention HIV/AIDS, Engagement in Care
Structural Basis of Protease-Activated Receptor Function Shaun R. Coughlin, MD, PhD HIV/AIDS, Drug and Diagnostics Development
Annual Program Statement for Microbicide Research, Development, and Introduction, Round 2 Tejal A. Desai, PhD HIV/AIDS, Women's Health, Risk Reduction and Prevention
TelePCC: Personalized Cognitive Counseling via Phone to Reduce HIV Risk in MSM James W. Dilley, MD HIV/AIDS, Engagement in Care, Treatment Adherence
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis David V. Glidden, PhD HIV/AIDS, Pharmacology and Drug Treatment
Translational evaluation of Aging, Inflammation, and HIV in Lung Dysfunction Ruth M. Greenblatt, MD HIV/AIDS, Chronic Respiratory Disease, Aging
The Connie Wofsy Women's HIV Study Ruth M. Greenblatt, MD HIV/AIDS, Opportunistic Infection, Women's Health
Longitudinal evaluation of HIV-associated lung disease phenotypes Ruth M. Greenblatt, MD HIV/AIDS, Chronic Respiratory Disease
HIV and Adiposity in Women: Effects on Bone Metabolism Ruth M. Greenblatt, MD HIV/AIDS, Women's Health
The Connie Wofsy Women's HIV Study Ruth M. Greenblatt, MD HIV/AIDS, Women's Health
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention, UCSF Professional Education, Patient and Peer Education
Consultation with the SFDPH HIV/AIDS surveillance unit Nancy Hessol, MSPH HIV/AIDS
HINT: HIV Immune Networks Team Modeling Core Nevan J. Krogan, PhD, MSc HIV/AIDS, Immunology
Center for AIDS Prevention Studies Marguerita A. Lightfoot, PhD HIV/AIDS, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
UCSF Prevention Research Center Marguerita A. Lightfoot, PhD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention, Patient and Peer Education
Substance Use and HIV Prevention Research in Minority Communities Training Program Marguerita A. Lightfoot, PhD HIV/AIDS, Substance Abuse
Social Media Messaging for HIV Testing in Zimbabwe Marguerita A. Lightfoot, PhD HIV/AIDS, Access or Barriers to Care, Engagement in Care
Implementation science, and behavioral interventions in support of HIV prevention Christina (Krysia) P. Lindan, MD, MSc HIV/AIDS, Implementation and Behavioral Science
Epigenetic control of virulence in a fungal meningitis pathogen Hiten D. Madhani, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
CRUSH: Connecting Resources for Urban Health Janet Myers, PhD HIV/AIDS, Patient and Peer Education
AIDS Education and Training Centers (AETC) National Evaluation Center (NEC) Janet Myers, PhD HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
Transgender Evaluation and Technical Assistance Center Greg M. Rebchook, PhD HIV/AIDS, Access or Barriers to Care
Transgender Evaluation and Technical Assistance Center Greg M. Rebchook, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD HIV/AIDS, Cardiovascular Disease, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Substance Abuse, Training and Capacity Building
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Infectious Disease, HIV/AIDS, Engagement in Care
System-level Workforce Capacity Building for Integrating HIV Primary Care in Community Healthcare Settings - Evaluation and Technical Assistance Center Wayne T. Steward, PhD, MSc HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting Norah A. Terrault, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Development of an HIV Self-testing Intervention to Reduce HIV risks among MSM: Taking the Guess Out of Seroguessing Chongyi Wei, DrPH HIV/AIDS, Access or Barriers to Care, Engagement in Care
Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach Chongyi Wei, DrPH HIV/AIDS, Engagement in Care
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling Sulggi A. Lee, MD HIV/AIDS, Immunology
A cognitive behavioral and structural HIV prevention intervention for young Ugandan women engaging in high risk sexual behavior Rachel King, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention
Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients Derek D. Satre, PhD HIV/AIDS, Substance Abuse
Alcohol Use and High Risk Behavior Among HIV-Positive Men Sarah Woolf-King, PhD, MPH HIV/AIDS, Substance Abuse
Alcohol and Condom Use among HIV+ Ugandan Adults: a Prospective Event-Level Study Sarah Woolf-King, PhD, MPH HIV/AIDS, Substance Abuse
Development and Validation of a Multidimensional Index of Engagement in HIV Care Mallory Johnson, PhD HIV/AIDS, Engagement in Care, Patient and Peer Education
Cerebrovascular mechanisms of HIV-associated cognitive impairment in China Felicia C. Chow, MD HIV/AIDS, Neurology and Mental Health
Evaluation of the Population-level Impact of PMTCT Option B+ Implemented in Zimbabwe Mi-Suk J. Kang Dufour, PhD, MPH HIV/AIDS, Women's Health, Pediatrics, Treatment Adherence, Risk Reduction and Prevention
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Addressing Health Disparities among Transgender Women Rachel Kaplan, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
Gender Based Violence and HIV Outcomes-Tracking and Treating Mental Illness Susan M. Meffert, MD, MPH HIV/AIDS, Neurology and Mental Health, Trauma and PTSD, Women's Health
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Strategic Partnership Alliance - Born Free and UCSF Eric Goosby, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
Gene expression outcomes in interventions for substance using HIV+ sexual minority men Annesa P. Flentje, PhD HIV/AIDS, Substance Abuse
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance
START: Study of Trauma and Reduction of HIV Transmission Kimberly M. Rush, RN, BSN HIV/AIDS, Trauma and PTSD, Implementation and Behavioral Science, Substance Abuse
Using Information to Align Services and Link and Retain Men in the HIV Cascade Shari L. Dworkin, PhD, MS HIV/AIDS, Engagement in Care, Patient and Peer Education
Relationship Factors and Engagement in HIV Care in Malawi: A Dyadic Investigation Amy Conroy, PhD HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells Timothy J. Henrich, MD HIV/AIDS, Drug and Diagnostics Development
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics Timothy J. Henrich, MD HIV/AIDS, Drug and Diagnostics Development
The transcriptional circuitry controlling biofilm development in Candida albicans Alexander D. Johnson, PhD Opportunistic Infection
Functional Testing of Host Genes that control HIV Latency in Primary Immune Cells Alexander Marson, MD, PhD HIV/AIDS, Immunology
Identifying barriers to diabetes and HIV co-management in vulnerable populations Kartika Palar, PhD HIV/AIDS, Diabetes, Women's Health
Effect of Metformin on Immune Recovery in HIV Patients with Diabetes Michael J. Reid, MD HIV/AIDS, Diabetes
p24 Antigen and Alternative Markers in Infants, Vietnam Annette H. Sohn, MD HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health
Dating Violence Prevention for Juvenile Justice Girls Marina Tolou-Shams, PhD HIV/AIDS, Adolescent Health, Patient and Peer Education
Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth Marina Tolou-Shams, PhD HIV/AIDS, Adolescent Health
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
PrEP disengagement in stimulant and heavy alcohol using men who have sex with men and transgender women. Jose Carlo Hojilla, PhD, MS HIV/AIDS, Substance Abuse
Blood safety standards and lab capacity in low & mid income countries Elizabeth Donegan, MD Infectious Disease, HIV/AIDS, Training International Scholars and Clinicians
HIV epidemiology among vulnerable populations in Iran Ali Mirzazadeh, PhD, MD, MPH HIV/AIDS, Women's Health, Access or Barriers to Care, Stigma and Discrimination, International Health Policy, Epidemiology and Surveillance
HARC Center: HIV Accessory and Regulatory Complexes Alan D. Frankel, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia Steven R. Stoltz, MD Opportunistic Infection, Chronic Respiratory Disease
The Better THAN Study: Targeting Heavy Alcohol with Naltrexone among MSM Glenn-Milo Santos, PhD, MPH HIV/AIDS, Implementation and Behavioral Science, Substance Abuse
Linkages Between Methamphetamine, Alcohol, and Sexual Risk Behavior Among PWID Glenn-Milo Santos, PhD, MPH HIV/AIDS, Substance Abuse
Long distance mentoring in global oncology Anu Agrawal, MD HIV/AIDS, Cancer/Oncology
Global Strategies for HIV Prevention Arthur Ammann, MD HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Access or Barriers to Care
Population-based sampling methods in HIV epidemiology Henry F. Raymond, DrPH, MPH HIV/AIDS, Epidemiology and Surveillance
HIV Global Strategic Information Education and Training in Kenya Sandy Schwarcz, MD, MPH HIV/AIDS
Burkitt’s lymphoma and Kaposi’s sarcoma in Uganda John Ziegler, MD, MSc Infectious Disease, HIV/AIDS
Antimalarial drugs in Ugandan populations Melissa Conrad, PhD HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics
Mental health and HIV in adolescents in Malawi Susan Kools, RN, PhD HIV/AIDS, Neurology and Mental Health, Adolescent Health
Social determinants and consequences of household food insecurity among persons living with HIV/AIDS Jason Nagata, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity
Clinical care and medical education David Sears, MD Infectious Disease, HIV/AIDS, Malaria
Aligning datasets for in-country decision making Hilary Spindler, MPH HIV/AIDS, Epidemiology and Surveillance, Global Strategic Information

Active Projects: 953

Project Investigator
All Topics Start date End date
Blood Donation and HIV Prevention in China Vincanne Adams, PhD HIV/AIDS
Dissertation Research: Resistant to Treatment: Medicine, Molecules, and the Global Politics of Drug-Resistant HIV Vincanne Adams, PhD HIV/AIDS
Recombinant Picornaviruses as AIDS Vaccines Raul Andino-Pavlovsky, PhD HIV/AIDS
Vaccine to Prevent HIV Infection in Pregnancy and Newborns Raul Andino-Pavlovsky, PhD HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health
Testing Sponsor's Antiretroviral Enzyme Immunoassay Method Francesca T. Aweeka, PharmD HIV/AIDS
2.1 Project Title ACTG: AIDS Clinical Trials Group Francesca T. Aweeka, PharmD Infectious Disease, HIV/AIDS, Tuberculosis
DDI study between HIV drugs (Efavirenz) and Coartem Francesca T. Aweeka, PharmD HIV/AIDS
IMPAACT: International Maternal Pediatrics Adolescent AIDS Clinic Francesca T. Aweeka, PharmD HIV/AIDS, Women's Health, Pediatrics
Pharmacokinetic analysis of dihydroartemisinin-piperaquine alongside the START-IPT Study Francesca T. Aweeka, PharmD HIV/AIDS, Malaria, Pediatrics
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award Francesca T. Aweeka, PharmD HIV/AIDS, Pediatrics
Adult AIDS Clinical Trials Group (AACTG): Pharmacology Support Laboratory Francesca T. Aweeka, PharmD HIV/AIDS
LOC-IMPAACT Leadership Group Francesca T. Aweeka, PharmD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development
ACTG: AIDS Clinical Trials Group; MASTER SUBCONTRACT -- U01AI068636 Francesca T. Aweeka, PharmD HIV/AIDS
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda Francesca T. Aweeka, PharmD HIV/AIDS, Malaria, Women's Health, Pediatrics
Pediatric AIDS Clinical Trial Group (PACTG) Pharmacology Support Laboratories Francesca T. Aweeka, PharmD HIV/AIDS
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Francesca T. Aweeka, PharmD HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health
International Maternal Pediatrics Adolescent AIDS Clinic (IMPAACT) Francesca T. Aweeka, PharmD HIV/AIDS, Malaria, Women's Health, Pediatrics
T003: International Maternal Pediatric Adolescent AIDS Clinical Trials Group IMPAACT Francesca T. Aweeka, PharmD HIV/AIDS, Women's Health, Pediatrics
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory Francesca T. Aweeka, PharmD HIV/AIDS
AIDS Clinical Trials Group Network Francesca T. Aweeka, PharmD HIV/AIDS
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum Sinem Beyhan-Pelvan, PhD Opportunistic Infection
HIV/STD Prevention Among Angolan Military Cherrie B. Boyer, PhD HIV/AIDS, Risk Reduction and Prevention, Patient and Peer Education
Leadership Group for the Adolescent Medicine Trials Network Cherrie B. Boyer, PhD HIV/AIDS, Adolescent Health
An Innovative HIV Prevention Curriculum for Medical Students of the University of Puerto Rico Medical School: Implementation and Evaluation Phase Cherrie B. Boyer, PhD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Adolescent Medicine Trials Network for HIV/AIDS Cherrie B. Boyer, PhD HIV/AIDS, Adolescent Health
Technical and Logistical Support for the Office of AIDS Research Cherrie B. Boyer, PhD HIV/AIDS
Identifying Opportunities for HIV Prevention among Female Migrants in Kenya Carol S. Camlin, PhD HIV/AIDS, Women's Health, Immigration and Migration, Risk Reduction and Prevention
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
Prevention Umbrella for MSM in the Americas Henry Chambers, MD HIV/AIDS
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Henry Chambers, MD HIV/AIDS, Opportunistic Infection
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus Henry Chambers, MD Opportunistic Infection
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
Prevention Umbrella for MSM in the Americas Henry Chambers, MD HIV/AIDS, Risk Reduction and Prevention
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Epidemiologic Analysis of Data from Project Aware to Determine the Impact of Different HIV Testing Strategies on Risk Behaviors and STD Rates among HIV-Uninfected MSM Henry Chambers, MD HIV/AIDS
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD HIV/AIDS, Tuberculosis, Epidemiology and Surveillance
Structural Alcohol Intervention to Reduce HIV Risk Behavior among Gay Bar Patrons Edwin D. Charlebois, PhD HIV/AIDS
Novel Evaluation Methods for Multi-Level/Combination HIV Prevention Interventions Edwin D. Charlebois, PhD HIV/AIDS
Structural Alcohol/HIV Risk Intervention in Gay Bar Patrons Edwin D. Charlebois, PhD HIV/AIDS, Risk Reduction and Prevention
Enhancing Care Engagement and Re-engagement Edwin D. Charlebois, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
Structural Alcohol/HIV RIsk Intervention in Gay Bar Patrons Edwin D. Charlebois, PhD HIV/AIDS
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis Edwin D. Charlebois, PhD HIV/AIDS, Tuberculosis, Implementation and Behavioral Science
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning, Pediatrics, Newborn and Infant Health
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3 Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Family Planning
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development
University of Zimbabwe-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Health Systems Strengthening, Training and Capacity Building
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
Developing a Network-based HIV Prevention Intervention for MSM in China [I] Kyung-Hee Choi, MPH, PhD HIV/AIDS
Integrating HIV/STI Prevention/Treatment in China Kyung-Hee Choi, MPH, PhD HIV/AIDS
Developing a Network-based HIV Prevention Intervention for MSM in China [II] Kyung-Hee Choi, MPH, PhD HIV/AIDS
An HIV Prevalence and Risk Behavior Survey of Male Sex Workers in Shanghai, China Kyung-Hee Choi, MPH, PhD HIV/AIDS
Influence of Stigma and Discrimination on HIV Risk among Men in China Kyung-Hee Choi, MPH, PhD HIV/AIDS, Risk Reduction and Prevention
Developing an HIV Prevention Intervention for HIV-Positive Men in China Kyung-Hee Choi, MPH, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
Social/Sexual Networks & HIV Risk: Men of Color Kyung-Hee Choi, MPH, PhD HIV/AIDS
Optimizing Rapid and Full Engagement in Care for Persons with Newly Diagnosed HIV Katerina Christopoulos, MD, MPH HIV/AIDS, Engagement in Care
The Medical Consequences of Different Types of Heroin Daniel H. Ciccarone, MD, MPH Infectious Disease, HIV/AIDS, Substance Abuse
HIV-HEP C Website Maintenance Services Susan C. Coffey, MD Infectious Disease, HIV/AIDS, Patient and Peer Education
AETC National Resource Center / AIDS Education and Training Website Susan C. Coffey, MD HIV/AIDS, Training and Capacity Building
Women, Children, and HIV Website Susan C. Coffey, MD HIV/AIDS, Women's Health, Patient and Peer Education
Adolescent Modules - AETC Web Site Susan C. Coffey, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Adolescent Modules - AETC Web Site (Cont.) Susan C. Coffey, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Women, Children, and HIV Website (DBS) Susan C. Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
UMDNJ / WHO Dept. of HIV/AIDS "Development of an Annotated Inventory of PMTCT Tools and Guidelines" Susan C. Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
VA HIV Website Susan C. Coffey, MD HIV/AIDS
Women, Children, and HIV Website Susan C. Coffey, MD HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Training and Capacity Building
UMDNJ / "Tanzania PMTCT Training Package" Susan C. Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Training and Capacity Building
VA HIV-HEP C Website Maintenance Services Susan C. Coffey, MD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education
AIDS Education and Training Center (AETC) National Resource Center / Website Susan C. Coffey, MD HIV/AIDS, Opportunistic Infection, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
National Resource Center for HIV/AIDS Prevention among Adolescents (APNRC) Susan C. Coffey, MD HIV/AIDS
Integrating Family Planning into HIV Care and Treatment Craig Cohen, MD, MPH HIV/AIDS
Pilot Agricultural Intervention for Food Security and HIV Outcomes in Kenya Craig Cohen, MD, MPH HIV/AIDS
HIV Shedding from the Female Genital Tract Craig Cohen, MD, MPH HIV/AIDS, Women's Health
Stakeholder Meeting on the Integration of Reproductive Health and HIV/AIDS Craig Cohen, MD, MPH HIV/AIDS, Women's Health
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Policy, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, International Health Policy, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Phase III Randomized , Placebo-Controlled Trial of HSV-2 Supression to Prevent HIV Transmission Among HIV Discordant Couples HSV-2/HIV Transmission Study Craig Cohen, MD, MPH HIV/AIDS
HIV Treatment for Research Subjects or By Researchers in Kenya Craig Cohen, MD, MPH HIV/AIDS
Travel Scholarships for Integration of Reproductive Health and HIV/AIDS Services Conference Craig Cohen, MD, MPH HIV/AIDS
Process Evaluation and Toolkit Development in Support of Family Planning Integration into HIV Care & Treatment in Kenya Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Family Planning, Newborn and Infant Health, Adolescent Health, Engagement in Care, Health Systems Strengthening
Accelerating Children's HIV/AIDS Treatment (ACT) initiative Craig Cohen, MD, MPH HIV/AIDS, Pediatrics, Access or Barriers to Care, Health Systems Strengthening, Training and Capacity Building
Impact of ART on Sexual Behaviors in Kisumu, Kenya Craig Cohen, MD, MPH HIV/AIDS
Integrating Family Planning Services into HIV Care and Treatment in Nyanza Province, Kenya - Phase II Craig Cohen, MD, MPH HIV/AIDS
(PrEP) Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV1 Acquisition within HIV1 Discordant Couples Craig Cohen, MD, MPH HIV/AIDS
HIV/HSV Study Completion Craig Cohen, MD, MPH HIV/AIDS
STAR STI CTG Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health
Integration of Family Planning into HIV Care and Treatment in Nyanza Province, Kenya Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Supporting the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in Kenya under PEPFAR Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Consequences of an Intervention to Promote the Pasteurization of Breastmilk to Reduce the Transmission of HIV from Mothers to Their Breastfed Infants Craig Cohen, MD, MPH HIV/AIDS
Development of a Live Topical Microbicide for Women Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Risk Reduction and Prevention
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
Secretion of Virulence Factors by Mycobacterium tuberculosis Infectious Disease, HIV/AIDS, Tuberculosis, Genetics
A Home-Based Couples Intervention to Enhance Prevention of Mother-to-Child-Transmission (PMTCT) and Family Health in Kenya Lynae Darbes, PhD HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence
New Challenges in HIV Prevention for Gay Male Couples Lynae Darbes, PhD HIV/AIDS
HIV prevention for male couples in Africa Lynae Darbes, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Risk Reduction and Prevention
Couples in Context: A Random Control Trial (RCT) of a Couples-Based HIV Prevention Lynae Darbes, PhD HIV/AIDS, Risk Reduction and Prevention
Couples-Based HIV Prevention in South Africa Lynae Darbes, PhD HIV/AIDS
HPV & Cervix Neoplasia in a Large, Long Term HIV+ Cohort Teresa M. Darragh, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
A Study Investigating the Association of HPV-Related Biomarkers with the Detection of Anal Precancer And Cancer in HIV-Positive Men Who Have Sex with Men (MSM) Teresa M. Darragh, MD HIV/AIDS, Cancer/Oncology
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors Teresa M. Darragh, MD HIV/AIDS, Cancer/Oncology, Women's Health
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors Teresa M. Darragh, MD HIV/AIDS, Cancer/Oncology, Women's Health
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans J. Luke Davis, MD HIV/AIDS
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans J. Luke Davis, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV J. Luke Davis, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans J. Luke Davis, MD HIV/AIDS
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting Carol S. Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Prevention for HIV-Positive Persons: An Intervention for HIV Care Providers Carol S. Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Prevention with Positives Carol S. Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Combination HIV Prevention for the General Population of Adults and Youth, including Persons Living with HIV in Mozambique Carol S. Dawson-Rose, RN, PhD, FAAN HIV/AIDS, Implementation and Behavioral Science
DARE: Delaney AIDS Research Enterprise to Find a Cure Steven G. Deeks, MD HIV/AIDS
Atripla Adherence and Resistance Relationships [II] Steven G. Deeks, MD HIV/AIDS, Treatment Adherence
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven G. Deeks, MD HIV/AIDS, Immunology, Women's Health
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven G. Deeks, MD HIV/AIDS, Drug and Diagnostics Development, Immunology, Genetics
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven G. Deeks, MD HIV/AIDS, Immunology, Genetics
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT Steven G. Deeks, MD HIV/AIDS
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven G. Deeks, MD HIV/AIDS, Women's Health
HIV Controllers: A Potential Model for HIV Eradication Steven G. Deeks, MD HIV/AIDS, Immunology
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven G. Deeks, MD HIV/AIDS
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven G. Deeks, MD HIV/AIDS, Immunology
Atripla Adherence and Resistance Relationships [I] Steven G. Deeks, MD HIV/AIDS, Treatment Adherence
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Specific T-Cell Responses in Rectal Mucosa Steven G. Deeks, MD HIV/AIDS
T Regulatory Cells and T Cell Activation in HIV Disease Steven G. Deeks, MD HIV/AIDS, Immunology
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven G. Deeks, MD HIV/AIDS
Characterizing the Role of Immune Activation in HIV Persistence Steven G. Deeks, MD HIV/AIDS, Immunology
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven G. Deeks, MD HIV/AIDS
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven G. Deeks, MD HIV/AIDS
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven G. Deeks, MD HIV/AIDS
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven G. Deeks, MD HIV/AIDS
Epigenetic Regulation of HIV Latency Steven G. Deeks, MD HIV/AIDS
Treatment Intensification for Drug-Resistant HIV Steven G. Deeks, MD HIV/AIDS
Innate Effector Function and HIV-1 Control Steven G. Deeks, MD HIV/AIDS, Immunology
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven G. Deeks, MD HIV/AIDS
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven G. Deeks, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Pharmacology and Drug Treatment
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT Steven G. Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven G. Deeks, MD HIV/AIDS
San Francisco National Clinical Trial Center, ESPIRIT Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD HIV/AIDS
HIV Entry Inhibitors: A New Therapeutic Option Steven G. Deeks, MD HIV/AIDS, Immunology
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven G. Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Impact of HIV-Associated Inflammation on Disease Steven G. Deeks, MD HIV/AIDS
Deeks Order CNICS: June 2014-Aug 2016 Steven G. Deeks, MD HIV/AIDS
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven G. Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Steven G. Deeks, MD HIV/AIDS
Elite Controllers Steven G. Deeks, MD HIV/AIDS, Immunology, Genetics
Interactions Between HIV and Malaria in African Children Matthew G. Dorsey, MD HIV/AIDS, Malaria
Enhancing HIV Treatment Adherence in South India: The Chetana study Maria L. Ekstrand, PhD HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
Context and Correlates of Health Behaviors in South India Maria L. Ekstrand, PhD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Substance Abuse
Examining ART Adherence Issues in Bangalore, India Maria L. Ekstrand, PhD HIV/AIDS, Treatment Adherence
Enhancing HIV treatment adherence in South India: The Chetana study Maria L. Ekstrand, PhD HIV/AIDS, Women's Health, Stigma and Discrimination, Implementation and Behavioral Science, Treatment Adherence
Examining ART Adherence Issues in Bangalore, India Maria L. Ekstrand, PhD HIV/AIDS
Asha HIV Health Promotion Intervention Maria L. Ekstrand, PhD HIV/AIDS
Homeless Female Offenders Returning to the Community: Improving Hopeful Futures Maria L. Ekstrand, PhD HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening
AIDS Stigma and Gender: Health Consequences in Urban India Maria L. Ekstrand, PhD HIV/AIDS
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV HIV/AIDS, Tuberculosis
Culture-Based Prediction of Adolescent HIV Risk Behavior Stephen L. Eyre, PhD HIV/AIDS, Adolescent Health, Risk Reduction and Prevention
Analysis of HIV-Specific Lymphocytes in Infants Using Single-Cell Microtools Margaret E. Feeney, MD HIV/AIDS
The Immune Response to Acute Perinatal HIV Infection Margaret E. Feeney, MD HIV/AIDS
The Impact of CD8 T Cells on Viral Control and Evolution in HIV-Infected Infants Margaret E. Feeney, MD HIV/AIDS
Japanese Health Professionals HIV/AIDS Training Program Mitchell D. Feldman, MD HIV/AIDS, Training International Scholars and Clinicians
HIV/AIDS Clinical Care Training Program for Japanese Physicians Mitchell D. Feldman, MD HIV/AIDS, Training and Capacity Building
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH HIV/AIDS
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Herpesviral Gene Expression in Kaposi's Sarcoma Donald E. Ganem, MD HIV/AIDS, Cancer/Oncology, Genetics
Evaluation of Haiti Quality Improvement of HIV Care Elvin H. Geng, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Health Systems Strengthening
Evaluation of Haiti Quality Improvement of HIV Care Elvin H. Geng, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa Elvin H. Geng, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Elvin H. Geng, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Engagement in Care
Tenofovir Kidney Toxicity Study Kathleen M. Giacomini, PhD HIV/AIDS, Pharmacology and Drug Treatment
Monitoring and Evaluating the State Legislative/Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-care Settings Ronald H. Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development
Health Marketing Services for the CDC Act Against AIDS campaigns: HIV Screening Standard Care for Primary Care Physicians (HSSC) & One Test Two Lives (OTTL) for Obstetrical Providers Ronald H. Goldschmidt, MD HIV/AIDS
The New York Pepline Ronald H. Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
National HIV Training and Technical Cooperative Agreements-Focus Area: HIV/AIDS Medical Homes Ronald H. Goldschmidt, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Training and Capacity Building
National HIV/AIDS Clinicians' Consultation Center Ronald H. Goldschmidt, MD HIV/AIDS
The New York PEPline Ronald H. Goldschmidt, MD HIV/AIDS, UCSF Professional Education, Patient and Peer Education
Monitoring and Evaluating the State Legislative /Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-Care Settings Ronald H. Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development
National HIV/AIDS Clinicians' Consultation Center Ronald H. Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building, UCSF Professional Education
UCSF - Ethiopia Fitun Warmline Ronald H. Goldschmidt, MD HIV/AIDS
Lutheran MC US-Caribbean HIV/AIDS Twinning Initiative Ronald H. Goldschmidt, MD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building
AIDS Education and Training Center, Telehealth Training Centers Program Ronald H. Goldschmidt, MD HIV/AIDS
Oral Manifestations of AIDS John S. Greenspan, BDS, PhD HIV/AIDS
HIV-Related Oral Diseases Among Women in Harare John S. Greenspan, BDS, PhD HIV/AIDS, Women's Health
For the Sarlo Teaching Award of the UCSF AIDS Research Institute John S. Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
Teaching in Excellence Award for the AIDS Research Institute John S. Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
Sarlo Award for Excellence in Teaching for the AIDS Research Institute at UCSF John S. Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
HIV Voluntary Testing and Counseling (VCT) and Linkage to Care in Uganda Judith A. Hahn, PhD, MD HIV/AIDS
Changes in Alcohol Consumption in HIV Positives in Uganda Judith A. Hahn, PhD, MD HIV/AIDS, Substance Abuse
Impact of Heavy Alcohol Use on Pre-ART HIV Disease -- Uganda ARCH Cohort Judith A. Hahn, PhD, MD HIV/AIDS, Substance Abuse
Measurement of Alcohol Use among HIV-Positives in Uganda Judith A. Hahn, PhD, MD HIV/AIDS
Integrating Alcohol Screening and Brief Intervention into HIV Care Judith A. Hahn, PhD, MD HIV/AIDS, Substance Abuse
Regulatory T Cell Influence on Infant and Adult Immune Responses to HIV Dennis Hartigan-O'Connor, MD, PhD HIV/AIDS
Oral Drug Treatment for Enhanced Immune Control over HIV Replication Dennis Hartigan-O'Connor, MD, PhD HIV/AIDS, Pharmacology and Drug Treatment
Virologic and Host Factors Contributing to HIV Control in Elite Controllers Hiroyu Hatano, MD, MHS HIV/AIDS
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients Hiroyu Hatano, MD, MHS HIV/AIDS, Immunology
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals Hiroyu Hatano, MD, MHS HIV/AIDS, Cardiovascular Disease
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir Hiroyu Hatano, MD, MHS HIV/AIDS
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Hiroyu Hatano, MD, MHS HIV/AIDS, Immunology
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study Hiroyu Hatano, MD, MHS HIV/AIDS, Pharmacology and Drug Treatment
Treating HIV-Infected Elite Controllers as a Model of HIV Remission Hiroyu Hatano, MD, MHS HIV/AIDS
Heals Endowment Fund at the East Bay Community Foundation Diane V. Havlir, MD HIV/AIDS
AIDS Research and Services at SF General Hospital Diane V. Havlir, MD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane V. Havlir, MD HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane V. Havlir, MD HIV/AIDS, Engagement in Care, Health Systems Strengthening, Training and Capacity Building
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) Diane V. Havlir, MD HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Diane V. Havlir, MD HIV/AIDS, Malaria
Training in HIV Primary Care - Uganda Clinicians Diane V. Havlir, MD HIV/AIDS, Training and Capacity Building
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
AIDS Clinical Trials Group (ACTG) TTSG Services Diane V. Havlir, MD HIV/AIDS
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane V. Havlir, MD HIV/AIDS, Cardiovascular Disease
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane V. Havlir, MD HIV/AIDS
Getting to Zero Coordinator/ SFPHF Diane V. Havlir, MD HIV/AIDS
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane V. Havlir, MD HIV/AIDS, Tuberculosis
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Training in HIV Translational Research Diane V. Havlir, MD HIV/AIDS, Training and Capacity Building
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane V. Havlir, MD HIV/AIDS, Tuberculosis
AIDS Clinical Trials Group (ACTG) Community Health Promoter Diane V. Havlir, MD HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane V. Havlir, MD HIV/AIDS, Tuberculosis
Task Order Supplement to A5267 Diane V. Havlir, MD HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment
AIDS Clinical Trials Group; Protocol Funds Diane V. Havlir, MD HIV/AIDS
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane V. Havlir, MD HIV/AIDS
Therapeutic Strategies for HIV Disease Diane V. Havlir, MD HIV/AIDS
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane V. Havlir, MD HIV/AIDS
UCSF HIV/AIDS Management Training Programs Diane V. Havlir, MD HIV/AIDS, Training and Capacity Building
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane V. Havlir, MD HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Diane V. Havlir, MD HIV/AIDS
International AIDS Research and Prevention Diane V. Havlir, MD HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) Diane V. Havlir, MD HIV/AIDS, Malaria
Task Order # 7: Supplement to SSS A5254 Diane V. Havlir, MD HIV/AIDS, Opportunistic Infection, Oral Health
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane V. Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane V. Havlir, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane V. Havlir, MD HIV/AIDS, Pediatrics
Clinical Studies of Interactions Between HIV and Malaria Diane V. Havlir, MD HIV/AIDS, Malaria
Task Order # 9: Supplement to SSS A5272 Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Reducing Failure-to-Initiate ART: Streamlined ART Start Diane V. Havlir, MD HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care
Neurological AIDS Research Consortium Diane V. Havlir, MD HIV/AIDS
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane V. Havlir, MD HIV/AIDS, Cardiovascular Disease
AIDS Research and Services at SFGH Diane V. Havlir, MD HIV/AIDS
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Diane V. Havlir, MD HIV/AIDS
Adult AIDS Clinical Trials Unit (AACTU) Diane V. Havlir, MD HIV/AIDS
Therapeutic Strategies for HIV Disease Diane V. Havlir, MD HIV/AIDS
Task Order # 6: Supplement to SSS A5257 Diane V. Havlir, MD HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane V. Havlir, MD HIV/AIDS, Tuberculosis
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane V. Havlir, MD HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane V. Havlir, MD HIV/AIDS, Tuberculosis
UCSF HIV Clinical Trials Unit Diane V. Havlir, MD HIV/AIDS
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane V. Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Developing an International Research Program in AIDS and Substance Abuse [II] Norman Hearst, MD, MPH HIV/AIDS
Developing an International Research Program in AIDS and Substance Abuse Norman Hearst, MD, MPH HIV/AIDS, Substance Abuse
Developing an International Research Program in AIDS and Substance Abuse [I] Norman Hearst, MD, MPH HIV/AIDS, Engagement in Care, Health Systems Strengthening
Improving and Evaluating HIV Response Implementation Norman Hearst, MD, MPH HIV/AIDS, Health Economics and Policy, International Health Policy
Effects of Exercise on Aging among Older Persons with HIV -- Pilot Study Frederick M. Hecht, MD HIV/AIDS, Diet, Exercise, and Obesity
Understanding the role of treatment timing cells and human genetics to explain why HIV drugs do not cure HIV Frederick M. Hecht, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
T Regulatory Cells in HIV Infection Frederick M. Hecht, MD HIV/AIDS, Immunology
The Biologic Determinants of HIV Transmission / HIV Applied Research Frederick M. Hecht, MD HIV/AIDS
The Biology of HIV Transmission Frederick M. Hecht, MD HIV/AIDS, Drug and Diagnostics Development
Comparison of Assays to Measure Viral Reservoirs in HIV Eradication Frederick M. Hecht, MD HIV/AIDS
Determinants of HIV Transmission Frederick M. Hecht, MD HIV/AIDS, Epidemiology and Surveillance
Characterization of Persistent HIV Viremia Frederick M. Hecht, MD HIV/AIDS
Options Project Frederick M. Hecht, MD HIV/AIDS
HIV Exposure in a Sample of HESN Men Having Sex with Men Frederick M. Hecht, MD HIV/AIDS
Posting at the Makerere University and Johns Hopkins University HIV Clinical Trials Unit in Kampala, Uganda Jaco Homsy, MD, MPH HIV/AIDS
Primary HIV Prevention in Pregnant and Lactating Ugandan Women Jaco Homsy, MD, MPH HIV/AIDS, Women's Health
HQHIV1003203 Philip Hopewell, MD HIV/AIDS, Tuberculosis
Effect of low dose methotrexate on endothelial function and inflammation in HIV Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients Priscilla Y. Hsue, MD HIV/AIDS, Epidemiology and Surveillance
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Effect of low dose methotrexate on endothelial function and inflammation in HIV Priscilla Y. Hsue, MD HIV/AIDS, Cardiovascular Disease
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD HIV/AIDS, Tuberculosis
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD HIV/AIDS
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD HIV/AIDS
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
PCP OPW Specimens Laurence Huang, MD Opportunistic Infection
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
Specimens Related to the MU-UCSF Research Collaboration Laurence Huang, MD HIV/AIDS
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD HIV/AIDS
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women Megan J. Huchko, MD HIV/AIDS, Cancer/Oncology
Mesalamine to Reduce T Cell Activation in HIV Infection Peter W. Hunt, MD HIV/AIDS, Drug and Diagnostics Development
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter W. Hunt, MD HIV/AIDS
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter W. Hunt, MD HIV/AIDS
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter W. Hunt, MD HIV/AIDS
HIV-Specific T-cell Responses in Rectal Mucosa Peter W. Hunt, MD HIV/AIDS
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Peter W. Hunt, MD HIV/AIDS
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans Peter W. Hunt, MD HIV/AIDS
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter W. Hunt, MD HIV/AIDS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Peter W. Hunt, MD HIV/AIDS
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter W. Hunt, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
Investigating Mechanisms of HIV Persistence in the Gut Peter W. Hunt, MD HIV/AIDS, Immunology
Intestinal MAIT Cells in HIV Infection Peter W. Hunt, MD HIV/AIDS
The Determinants of T Cell Activation in HIV Infection Peter W. Hunt, MD HIV/AIDS
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection Peter W. Hunt, MD HIV/AIDS
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Pharmacology and Drug Treatment
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART HIV/AIDS
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
AIDS Malignancies Consortium Lawrence D. Kaplan, MD HIV/AIDS, Cancer/Oncology
NIMH Collaborative HIV/STD Prevention Trial Susan M. Kegeles, PhD HIV/AIDS
NIMH Collaborative HIV/STD Prevention Trial Susan M. Kegeles, PhD HIV/AIDS
Traineeships in AIDS Prevention Studies Susan M. Kegeles, PhD HIV/AIDS
Moving a Research-Based Intervention into Practice Susan M. Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
Mpowerment Project Training Agreement Susan M. Kegeles, PhD HIV/AIDS, Adolescent Health, Training and Capacity Building, Patient and Peer Education
Mpowerment Project Training Agreement Susan M. Kegeles, PhD HIV/AIDS, Training and Capacity Building, Patient and Peer Education
Mpowerment Project Training Agreement Susan M. Kegeles, PhD HIV/AIDS, Adolescent Health, Risk Reduction and Prevention, Patient and Peer Education
HIV Prevention for Transgender Individuals Susan M. Kegeles, PhD HIV/AIDS, Engagement in Care
Multilevel HIV Prevention Intervention for Young African American Men Susan M. Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
NIMH Collaborative HIV/STD Prevention Trial Susan M. Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science
Community-level HIV Prevention Intervention for Young Black Men Susan M. Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care
Traineeships in AIDS Prevention Studies Susan M. Kegeles, PhD HIV/AIDS, Neurology and Mental Health, Implementation and Behavioral Science, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
HIV Prevention for African American Down Low Men Susan M. Kegeles, PhD HIV/AIDS, Engagement in Care, Risk Reduction and Prevention, Patient and Peer Education
Faith-based HIV Prevention for African American MSM Susan M. Kegeles, PhD HIV/AIDS
HIV Translation Research for Young African American MSM Susan M. Kegeles, PhD HIV/AIDS, Access or Barriers to Care, Engagement in Care, Risk Reduction and Prevention
HIV Prevention for African American Down Low Men Susan M. Kegeles, PhD HIV/AIDS, Engagement in Care
Web-Based, Structural HIV Prevention in MSM's Networks Susan M. Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
Development of a Multilevel HIV Prevention for Latin American Men Susan M. Kegeles, PhD HIV/AIDS
Innate Immunity and Autophagy in Elite Controllers Michael S. Killian, PhD, MPH HIV/AIDS
Studies of Ocular Complications of AIDS (SOCA) Charles C. Kim, PhD HIV/AIDS, Eye Disease and Blindness
Health Empowerment for MSM in South Africa Timothy E. Lane, PhD, MPH HIV/AIDS
HIV Evaluation Activities with High-Risk, Underserved Populations in South Africa Timothy E. Lane, PhD, MPH HIV/AIDS, Implementation and Behavioral Science
HIV Prevention among High-Risk Men in South Africa Timothy E. Lane, PhD, MPH HIV/AIDS
JCF/Bransten Grant Jay A. Levy, MD HIV/AIDS
Role of Innate Immunity in Controlling HIV Infection Jay A. Levy, MD HIV/AIDS
HIV cure with CCR5 negative human IPS hematopoietic stem cells Jay A. Levy, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
JCF/Hellman Grant Jay A. Levy, MD HIV/AIDS
Protection from HIV Infection in Intravenous Drug Users Jay A. Levy, MD HIV/AIDS, Substance Abuse, Risk Reduction and Prevention
Identification of the CD8 Cell Anti-HIV Factor (CAF) Jay A. Levy, MD HIV/AIDS
Immunologic and Virologic Features of Early HIV Infection Jay A. Levy, MD HIV/AIDS, Risk Reduction and Prevention
Role of Innate Immunity in Controlling HIV Infection Jay A. Levy, MD HIV/AIDS
Identification of the CD8+Cell Anti-HIV Factor (CAF) Jay A. Levy, MD HIV/AIDS, Immunology
Role of Innate Immunity in Controlling HIV Infection Jay A. Levy, MD HIV/AIDS
Molecular Epidemiology of the Human Immunodeficiency Virus in Mexico Jay A. Levy, MD HIV/AIDS
Identification of the CD8+ Cell Anti-HIV Factor (CAF) Jay A. Levy, MD HIV/AIDS, Immunology
UCSF AIDS Research Training Program Jay A. Levy, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Identification of the CD8+ Cell Antiviral Factor (CAF) Jay A. Levy, MD HIV/AIDS
Subcontract from UFL Prime: HIV/FIV-Cat-Model: A model to identify vaccine epitopes Jay A. Levy, MD HIV/AIDS
Role of Innate Immunity in Controlling HIV Infection Jay A. Levy, MD HIV/AIDS
HIV cure with CCR5 (-) human IPS hematopoietic stem cells Jay A. Levy, MD HIV/AIDS, Risk Reduction and Prevention
Prevention Umbrella for MSM in the Americas Sheri A. Lippman, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services Sheri A. Lippman, PhD, MPH HIV/AIDS, Systematic Reviews and Guideline Development
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services Sheri A. Lippman, PhD, MPH HIV/AIDS
Self-Conducted HIV Tests - Improving HIV Prevention in Key Populations Sheri A. Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care, Engagement in Care
Does Shifting Gender Norms on the Community Level Lead to Increased HIV Services Uptake? Sheri A. Lippman, PhD, MPH HIV/AIDS, Stigma and Discrimination, Patient and Peer Education
Toward Understanding Community Mobilization for HIV Prevention in the African Context Sheri A. Lippman, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne F. Luetkemeyer, MD HIV/AIDS
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne F. Luetkemeyer, MD HIV/AIDS
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne F. Luetkemeyer, MD HIV/AIDS
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne F. Luetkemeyer, MD HIV/AIDS
Pfizer A4001027: Observational Phase Extension Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne F. Luetkemeyer, MD HIV/AIDS
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Gilead GS-US-236-0102 Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne F. Luetkemeyer, MD HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne F. Luetkemeyer, MD HIV/AIDS, Tuberculosis
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV Anne F. Luetkemeyer, MD HIV/AIDS
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne F. Luetkemeyer, MD HIV/AIDS, Cancer/Oncology
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne F. Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne F. Luetkemeyer, MD HIV/AIDS
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne F. Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey N. Martin, MD, MPH HIV/AIDS
Uganda-UCSF Research Training Program in HIV-Associated Malignancies Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Unsolicited R24 for the CFAR - Network of Integrated Clinical Sciences (CNICS) Jeffrey N. Martin, MD, MPH HIV/AIDS
Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey N. Martin, MD, MPH HIV/AIDS
Implementation science to optimize HIV prevention in East Africa PEPFAR program Jeffrey N. Martin, MD, MPH HIV/AIDS
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Gilead Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey N. Martin, MD, MPH HIV/AIDS
Cohort Study of Patients Receiving Long-Term Combination Therapy [II] Jeffrey N. Martin, MD, MPH HIV/AIDS, Drug and Diagnostics Development
NAAccord (CHK-UP on HIV Supplement) Jeffrey N. Martin, MD, MPH HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
East Africa IEDEA Regional Consortium Jeffrey N. Martin, MD, MPH HIV/AIDS
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey N. Martin, MD, MPH HIV/AIDS, Cancer/Oncology
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study Toby A. Maurer, MD Infectious Disease, HIV/AIDS, Women's Health
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology
Effects of Maraviroc on HIV-related Kaposi Sarcoma Toby A. Maurer, MD HIV/AIDS, Cancer/Oncology
Disulfiram Interactions With HIV Medications: Clinical Implications Elinore F. McCance-Katz, MD, PhD HIV/AIDS
Opioids & HIV Medications: Interactions in Drug Abusers Elinore F. McCance-Katz, MD, PhD HIV/AIDS
Role of Buprenorphine in Improving Clinicial Care in Opioid Addiction and HIV Elinore F. McCance-Katz, MD, PhD HIV/AIDS, Pharmacology and Drug Treatment, Substance Abuse
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection Elinore F. McCance-Katz, MD, PhD HIV/AIDS
Inflammation and HIV Persistence J. Michael McCune, MD, PhD HIV/AIDS
HIV Proteomic Center for Host-Viral Responses Characterization J. Michael McCune, MD, PhD HIV/AIDS
Defining critical events in early HIV infection-effects of alcohol and early ART J. Michael McCune, MD, PhD HIV/AIDS, Immunology, Substance Abuse
Detection and Measurement of the HIV Reservoir J. Michael McCune, MD, PhD HIV/AIDS
HIV Proteomic Center for Host-Viral Responses Characterization J. Michael McCune, MD, PhD HIV/AIDS
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 J. Michael McCune, MD, PhD HIV/AIDS, Immunology
Interruption of Maternal-Fetal Transmission of HIV J. Michael McCune, MD, PhD HIV/AIDS, Women's Health
Interferon-independent mechanisms of malaria restriction by helper T cells J. Michael McCune, MD, PhD HIV/AIDS, Malaria, Immunology
Exchange of samples- Placental Biopsies J. Michael McCune, MD, PhD HIV/AIDS, Women's Health
Thymic Function in Adults With HIV-1 Disease J. Michael McCune, MD, PhD HIV/AIDS
Novel flow cytometry-based assay for HIV-infected cells J. Michael McCune, MD, PhD HIV/AIDS, Risk Reduction and Prevention
HIV Effects on the Central Hematolymphoid System J. Michael McCune, MD, PhD HIV/AIDS
HIV Effects on the Central Hematolymphoid System J. Michael McCune, MD, PhD HIV/AIDS
Design of an Effective Vaccine against HIV: An Alternative Hypothesis J. Michael McCune, MD, PhD HIV/AIDS
Design of an Effective Vaccine against HIV: An Alternative Hypothesis J. Michael McCune, MD, PhD HIV/AIDS
Assessing Laboratory Correlates of Immune Protection J. Michael McCune, MD, PhD HIV/AIDS
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings John J. Metcalfe, MD HIV/AIDS, Tuberculosis
Development and Validation of a Diagnostic Tool for HIV Dementia Ana-Claire L. Meyer, MD HIV/AIDS, Dementia and Cognitive Impairment
The Development of a Tool to Identify Peripheral Neuropathy and HIV Associated Dementia Ana-Claire L. Meyer, MD HIV/AIDS, Dementia and Cognitive Impairment
The Development of a Tool to Identify Peripheral Neuropathy and HIV Associated Dementia Ana-Claire L. Meyer, MD HIV/AIDS, Dementia and Cognitive Impairment
Treatment of HIV-Associated Cognitive Impairment Ana-Claire L. Meyer, MD HIV/AIDS
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients Ana-Claire L. Meyer, MD HIV/AIDS
New Combination Therapies for Early Cryptococcal Infection in HIV Infected Individuals: A Randomized Controlled Trial Ana-Claire L. Meyer, MD HIV/AIDS
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa Dominic D. Montagu, DrPH HIV/AIDS, Tuberculosis, Health Economics and Policy
Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS Stephen F. Morin, PhD HIV/AIDS, Engagement in Care, Risk Reduction and Prevention
Center for AIDS Prevention Studies Stephen F. Morin, PhD HIV/AIDS
AIDS Policy Research Center [II] Stephen F. Morin, PhD HIV/AIDS, Health Economics and Policy, Access or Barriers to Care, Epidemiology and Surveillance, Implementation and Behavioral Science, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
Using ELI Data to Guide HIV Prevention in California Stephen F. Morin, PhD HIV/AIDS, Epidemiology and Surveillance
Community-Based HIV VCT: Zimbabwe Stephen F. Morin, PhD HIV/AIDS, Risk Reduction and Prevention
Center for AIDS Prevention Studies (CAPS) Stephen F. Morin, PhD HIV/AIDS, Risk Reduction and Prevention
AIDS Policy Research Center Stephen F. Morin, PhD HIV/AIDS, Health Economics and Policy
Community-based VCT: Zimbabwe Stephen F. Morin, PhD HIV/AIDS
HIV Testing, Prevention and Treatment in Health Centers Survey Tool Stephen F. Morin, PhD HIV/AIDS, Patient and Peer Education
Understanding the Acceptability of Pre-Exposure Prophylaxis (PrEP) to Prevent HIV among Men Who Have Sex with Men and Transgender People in California Stephen F. Morin, PhD HIV/AIDS, Risk Reduction and Prevention
Health-Related Interventions for Persons Living with HIV Stephen F. Morin, PhD HIV/AIDS, Systematic Reviews and Guideline Development
Center for AIDS Prevention Studies Stephen F. Morin, PhD HIV/AIDS
AIDS Policy Research Center [I] Stephen F. Morin, PhD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
Building Community Partnerships: Case Studies at Three HPTN Sites Stephen F. Morin, PhD HIV/AIDS, Health Systems Strengthening, Training International Scholars and Clinicians
Pediatric HIV/AIDS Cohort Study (PHACS) Anna-Barbara Moscicki, MD HIV/AIDS, Pediatrics, Adolescent Health
HPV Infections and Associated Morbidity in Children and Adolescents Perinatally Infected with HIV Anna-Barbara Moscicki, MD HIV/AIDS, Pediatrics, Epidemiology and Surveillance
A San Francisco Street Youth Cohort: At-Risk and HIV+ Anna-Barbara Moscicki, MD HIV/AIDS, Adolescent Health, Engagement in Care, Risk Reduction and Prevention, Training and Capacity Building, Patient and Peer Education
Positive Affect Regulation for HIV Prevention in People with Mood Disorders Judith T. Moskowitz, PhD, MPH HIV/AIDS
A Positive Affect Intervention for Those Recently Diagnosed with HIV Judith T. Moskowitz, PhD, MPH HIV/AIDS, Implementation and Behavioral Science
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Hub Edward L. Murphy, MD, MPH HIV/AIDS, Epidemiology and Surveillance
XV International Conference on Human Retrovirology: HTLV and Related Viruses Edward L. Murphy, MD, MPH Infectious Disease, HIV/AIDS
XI International Conference on Human Retrovirology: HTLV Edward L. Murphy, MD, MPH HIV/AIDS
Relationship Power and HIV Risk in Gay Male Couples Torsten B. Neilands, PhD HIV/AIDS, Implementation and Behavioral Science
The Collaborative HIV Prevention Research in Minority Communities Program Torsten B. Neilands, PhD HIV/AIDS
Migration, Tourism and the HIV-drug use Syndemic in the Dominican Republic Torsten B. Neilands, PhD HIV/AIDS, Immigration and Migration, Epidemiology and Surveillance, Substance Abuse
AIDS Stigma Among Health Professionals in Puerto Rico Torsten B. Neilands, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Implementation and Behavioral Science
Collaborative HIV Prevention in Minority Communities Torsten B. Neilands, PhD HIV/AIDS
NIH Study of HIV/AIDS Stigma Reduction Torsten B. Neilands, PhD HIV/AIDS
Minority Communities HIV Prevention Research Training Torsten B. Neilands, PhD HIV/AIDS, Training and Capacity Building
Improving HAART Adherence in HIV+ Active Drug Users HIV/AIDS
Innate Natural Killer T (NKT) Cells in HIV Infection Douglas Nixon, MD, PhD HIV/AIDS
Chemoprohylaxis and HIV-Host Interactions Douglas Nixon, MD, PhD HIV/AIDS
Eliminating the Latent Reservoir through Self-Specific Antibodies Douglas Nixon, MD, PhD HIV/AIDS
Chemoprophylaxis and HIV-Host Interactions [II] Douglas Nixon, MD, PhD HIV/AIDS, Immunology
Viral Tropism and Immune Control in HIV Douglas Nixon, MD, PhD HIV/AIDS
Innate NKT Cells in HIV Infection Douglas Nixon, MD, PhD HIV/AIDS
Innate NKT Cells in HIV Infection Douglas Nixon, MD, PhD HIV/AIDS
Protective Immunity in HIV Highly Exposed but Uninfected Subjects Douglas Nixon, MD, PhD HIV/AIDS
Human Endogenous Retroelements in HIV Immunopathogenesis Douglas Nixon, MD, PhD HIV/AIDS
Immunological Targeting of APOBEC Proteins to Cure HIV Infection Douglas Nixon, MD, PhD HIV/AIDS, Immunology
An Endogenous Retroelement Vaccine against HIV-1 Douglas Nixon, MD, PhD HIV/AIDS
Protective immunity in HIV Highly Exposed but Uninfected Subjects Douglas Nixon, MD, PhD HIV/AIDS
T Regulatory Cells in HIV Infection Douglas Nixon, MD, PhD HIV/AIDS
Cell Mediated Immunity in HIV-Infected Children Douglas Nixon, MD, PhD HIV/AIDS
A Novel APOBEC-Based Vaccine Approach for HIV Douglas Nixon, MD, PhD HIV/AIDS
Enhanced HIV Prevention in the Republic of Uganda HIV/AIDS, Implementation and Behavioral Science
Safety and Pharmacokinetics of Tenofovir and Emtricitabine in HIV Negative Thai Women Kimberly A. Page, PhD, MPH HIV/AIDS, Women's Health, Risk Reduction and Prevention
Chemoprophylaxis for HIV Prevention in Peruvian Men Kimberly A. Page, PhD, MPH HIV/AIDS
Cambodia Integrated HIV and Drug Prevention Implementation Program Kimberly A. Page, PhD, MPH HIV/AIDS
Amphetamine-Type Stimulant (ATS) Use HIV among Young Female Sex and Entertainment Workers in Cambodia Kimberly A. Page, PhD, MPH HIV/AIDS
Culture and HIV Prevention in Cambodia Kimberly A. Page, PhD, MPH HIV/AIDS, Implementation and Behavioral Science
Health Evaluation of the Young Man Study Kimberly A. Page, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Risk Reduction and Prevention
International Collaborative of Prospective Studies of HIV and Hepatitis in IDU Kimberly A. Page, PhD, MPH HIV/AIDS, Substance Abuse
Phase 1/2 Trial of Pharmacological HIV-1 Prevention Kimberly A. Page, PhD, MPH HIV/AIDS
Chemoprophylaxis and HIV-Host Interactions [I] Kimberly A. Page, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Natural History of Anal Neoplasia in HIV-Infected Men Joel Palefsky, MD HIV/AIDS
Doris Duke Charitable Foundation International Clinical Research Fellowship Program Joel Palefsky, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Cidofovir for Perianal Dysplasia in HIV Patients Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
HPV testing of samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Anal HPV Infection and ASIL in HIV+ and HIV- Women Joel Palefsky, MD HIV/AIDS, Women's Health
HIV Facilitated Paracellular Penetration of HPV across Mucosal Epithelium Joel Palefsky, MD HIV/AIDS
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females Joel Palefsky, MD HIV/AIDS
California Division Special Research Scholar Grant in HIV-Related Cancers Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Cancer/Oncology, Women's Health
HPV Testing of Samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS